Skip to main content
. 2022 Jun 1;112(1):75–86. doi: 10.1007/s00392-022-02036-9

Table 3.

Congestion on admission and at discharge

All patients Patients without event Patients with event p-value
n = 130 n = 70 n = 60
Admission
 NYHA class 0.839
  II 4 (3.08%) 2 (2.86%) 2 (3.33%)
  III 84 (64.6%) 47 (67.1%) 37 (61.7%)
  IV 42 (32.3%) 21 (30.0%) 21 (35.0%)
Rales 0.281
 Absent 23 (17.7%) 15 (21.4%) 8 (13.3%)
   < 1/3 70 (53.8%) 33 (47.1%) 37 (61.7%)
  1/3–2/3 36 (27.7%) 21 (30.0%) 15 (25.0%)
   > 2/3 1 (0.77%) 1 (1.43%) 0 (0.00%)
Edema 0.205
 Absent 4 (3.08%) 4 (5.71%) 0 (0.00%)
 1 +  32 (24.6%) 17 (24.3%) 15 (25.0%)
 2 +  54 (41.5%) 31 (44.3%) 23 (38.3%)
 3 +  40 (30.8%) 18 (25.7%) 22 (36.7%)
Jugular venous pressure 0.815
  < 6 cm H2O 35 (26.9%) 19 (27.1%) 16 (26.7%)
 6–10 cm H2O 20 (15.4%) 12 (17.1%) 8 (13.3%)
  > 10 cm H2O 75 (57.7%) 39 (55.7%) 36 (60.0%)
 Congestion score 5.00 [4.00;5.75] 4.00 [3.00;6.00] 5.00 [4.00;5.00] 0.481
  IVCmax, mm 25 [23;29] 25 [23;27] 25 [23;29] 0.276
  DVAS, cm 5.6 [3.7;7.5] 5.5 [4.3;7.5] 5.8 [2.5;7.5] 0.848
  NT-proBNP, ng/l 4011 [2103;8107] 3904 [2103;6981] 4585 [2132;9528] 0.422
Discharge
 NYHA class 0.571
  I 30 (23.1%) 17 (24.3%) 13 (21.7%)
  II 61 (46.9%) 35 (50.0%) 26 (43.3%)
  III 35 (26.9%) 17 (24.3%) 18 (30.0%)
  IV 4 (3.08%) 1 (1.43%) 3 (5.00%)
Rales 0.463
 Absent 100 (76.9%) 56 (80.0%) 44 (73.3%)
  < 1/3 21 (16.2%) 11 (15.7%) 10 (16.7%)
 1/3–2/3 9 (6.92%) 3 (4.29%) 6 (10.0%)
Edema 0.264
 Absent 77 (59.2%) 46 (65.7%) 31 (51.7%)
 1 +  43 (33.1%) 20 (28.6%) 23 (38.3%)
 2 +  10 (7.69%) 4 (5.71%) 6 (10.0%)
Jugular venous pressure 0.320
  < 6 cm H2O 94 (72.3%) 53 (75.7%) 41 (68.3%)
 6–10 cm H2O 12 (9.23%) 4 (5.71%) 8 (13.3%)
  > 10 cm H2O 24 (18.5%) 13 (18.6%) 11 (18.3%)
Congestion score 1.00 [0.00;2.00] 1.00 [0.00;2.00] 1.00 [0.75;2.00] 0.011
IVCmax, mm 21 [19;26] 21 [19;25] 21 [19;27] 0.404
DVAS, cm 1.8 [0.4;3.0] 1.8 [0.5;2.7] 1.7 [0.1;3.3] 0.903
NT-proBNP, ng/l 2160 [988;5283] 1826 [794;3291] 2992 [1707;7352] 0.002

Congestion markers on admission and at baseline based on the first imputed dataset. Values are median (interquartile range) or number of patients (%). IVCmax maximum inferior vena cava diameter, NT-proBNP N-terminal pro–B-type natriuretic peptide, NYHA  New York Heart Association, DVAS  visual analogue scale for dyspnea